Trial Profile
An Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Baloxavir Marboxil 2% Granules after Administration of a Single Dose to Otherwise Healthy Pediatric Patients with Influenza
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Dec 2021
Price :
$35
*
At a glance
- Drugs Baloxavir-marboxil (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Adverse reactions
- Sponsors Shionogi Pharma
- 21 Dec 2021 New trial record